1-methyl-4-phenylpyridinium has been researched along with Genetic Predisposition in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aiastui, A; Bravo-San Pedro, JM; Climent, V; Fuentes, JM; Gómez-Sánchez, R; González-Polo, RA; López de Munain, A; Pizarro-Estrella, E; Rodríguez-Arribas, M; Yakhine-Diop, SM | 1 |
| Chen, CM; Chen, IC; Chen, YC; Chen, YL; Huang, YC; Juan, HF; Lai, YJ; Lee, CM; Lee, LC; Lee-Chen, GJ; Lin, CH; Wu, YR | 1 |
| Liu, L; Wang, X; Wang, Y | 1 |
| Halliwell, B; Hyun, DH; Jenner, P; Lee, M | 1 |
4 other study(ies) available for 1-methyl-4-phenylpyridinium and Genetic Predisposition
| Article | Year |
|---|---|
G2019S LRRK2 mutant fibroblasts from Parkinson's disease patients show increased sensitivity to neurotoxin 1-methyl-4-phenylpyridinium dependent of autophagy.
Topics: 1-Methyl-4-phenylpyridinium; Adenine; Autophagy; Case-Control Studies; Caspases; Cells, Cultured; Dose-Response Relationship, Drug; Fibroblasts; Gene-Environment Interaction; Genetic Predisposition to Disease; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Lysosomes; Macrolides; Mutation; Parkinson Disease; Phenotype; Protein Serine-Threonine Kinases; Risk Factors; TOR Serine-Threonine Kinases; Transfection | 2014 |
FBXO7 Y52C polymorphism as a potential protective factor in Parkinson's disease.
Topics: 1-Methyl-4-phenylpyridinium; Adult; Amino Acid Sequence; Animals; Case-Control Studies; Cell Line, Tumor; Cell Survival; F-Box Proteins; Female; Gene Expression Regulation; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Models, Molecular; Molecular Sequence Data; Mutation; Parkinson Disease; Polymorphism, Single Nucleotide; Protective Factors; Protein Stability; Protein Structure, Secondary; Sequence Homology, Amino Acid; TNF Receptor-Associated Factor 2; Ubiquitination; Young Adult | 2014 |
HDAC inhibitor trichostatin A-inhibited survival of dopaminergic neuronal cells.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Antiparkinson Agents; Apoptosis; Cell Line; Cell Survival; Dopamine; Drug Evaluation, Preclinical; Genetic Predisposition to Disease; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Mice; Nerve Degeneration; Neurons; Parkinson Disease; Rats; Rotenone; Substantia Nigra | 2009 |
Effect of overexpression of wild-type or mutant parkin on the cellular response induced by toxic insults.
Topics: 1-Methyl-4-phenylpyridinium; Acetylcysteine; Aldehydes; Apoptosis; Cell Death; Cell Line, Tumor; Drug Resistance; Enzyme Inhibitors; Genetic Predisposition to Disease; Glutamic Acid; Guanine; Humans; Hydrogen Peroxide; Mutation; Nerve Degeneration; Neurons; Neurotoxins; Oxidative Stress; Parkinsonian Disorders; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Substantia Nigra; Tyrosine; Ubiquitin-Protein Ligases | 2005 |